Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Hamburg - Delayed Quote • EUR L'Oreal SA (LOR.HM) Follow Compare 353.05 -0.95 (-0.27%) As of 11:54:47 AM GMT+1. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations L’Oreal expands US footprint with new $160m research site in New Jersey Spanning 23,226 sqm, the new $160m research and innovation centre will focus on developing products for its North American brands. L’Oreal Opens $160 Million R&D Center in New Jersey The facility created more than 600 new jobs. Disclosure of total number of voting rights and number of shares in the capital at January 31, 2025 French limited company (Société anonyme) with registered capital of 106,862,404.20 eurosRegistered office: 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifier: 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at January 31, 2025 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF's General Regulations: Total number of shares534,312,021Number of real voting rights (excluding treasury shares HELE or LRLCY: Which Is the Better Value Stock Right Now? HELE vs. LRLCY: Which Stock Is the Better Value Option? L'Oreal SA (LRLCF) (FY 2024) Earnings Call Highlights: Record Growth and Strategic Innovations L'Oreal SA (LRLCF) reports a robust fiscal year with record-high margins and strategic advancements despite challenges in North Asia. L'Oreal takes stakes in Chinese, N.American clinics to understand medical aesthetics market L'Oreal has taken stakes in clinics in China and North America in order to observe and understand the medical aesthetics market, L'Oreal CEO Nicolas Hieronimus said in an earnings call on Friday. The company had announced in August the acquisition of a 10% stake in Swiss skin care firm Galderma. Hieronimus added that L'Oreal would be entering the nutricosmetics market with a new product and said more would be coming. L'Oreal CEO bullish on US as China sales stay weak PARIS (Reuters) -Cosmetics giant L'Oreal is upbeat on the United States for the year ahead, it said on Friday, even as its shares were dragged down by its slowest quarterly sales since the height of the pandemic, following weak Chinese demand. L'Oreal has been popular for years among investors for outperforming peers, but persistently weak demand for consumer goods in China, where it has a significant market share, has affected its business. The Paris-listed shares were down by over 4% around 0912 GMT, as investors were concerned that sales also stayed below expectations in North America, as well as in the firm's luxury segment. L'Oreal quarterly sales grow at slowest since the pandemic French cosmetics group L'Oreal reported on Thursday the slowest quarterly rise in growth since the height of the pandemic, missing expectations, as Chinese demand stayed weak and growth in North America slowed. The 2.5% rise in fourth-quarter sales was a slowdown from the 3.4% rise in the third quarter, and the slowest quarterly growth since 2020. The company had said in October fourth-quarter sales growth would be comparable to the prior quarter's. 2024 Annual Results Solid +5.1% Growth in a Challenging Context Record Results, Reaching 20% Operating Margin Sales: 43.48 billion euros, +5.6% reported and +5.1% like-for-like1. Another year of outperformance in a normalising global beauty market. Like-for-like growth in all Divisions with three out of four outperforming the market. Like-for-like growth in all regions except North Asia. Growth driven by both value and volume. Record operating margin at 20.0% (+20bps and +40bps excluding Aesop). Earnings per share2 Trending tickers: Amazon, Qualcomm, Arm, Nissan and AstraZeneca The latest investor updates on stocks that are trending on Thursday. Sanofi kicks off share buyback plan with $3bn L’Oréal stake purchase L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%. Trending tickers: Palantir, Alibaba, TSMC, Toyota and Antofagasta The latest investor updates on stocks that are trending on Monday. Agreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’Oréal AGREEMENT BETWEEN L’ORÉAL AND SANOFI FOR THE REPURCHASEBY SANOFI OF 2.3% OF ITS OWN SHARES HELD BY L’ORÉAL Clichy, February 3, 2025 – L’Oréal announces today that it has agreed to sell approximately 29.6 million of Sanofi shares to Sanofi for €101.5 per share, for a total consideration of €3 billion. Upon completion of the transaction and cancellation of the repurchased shares, L’Oréal will own 7.2% of Sanofi’s share capital and 13.1% of its voting rights1. L’Oréal remains an important sharehold Stocks to watch this week: Amazon, Palantir, Disney, Novo Nordisk and AstraZeneca Earnings preview of key companies reporting this week and what to look out for. Disclosure of total number of voting rights and number of shares in the capital at December 31, 2024 French limited company (Société anonyme) with registered capital of 106,862,389.20 eurosRegistered office: 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifier: 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at December 31, 2024 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF's General Regulations: Total number of shares 534,312,021 Number of real voting rights (excluding treasury sha IBM, L'Oreal Team Up to Drive Sustainable Innovation With AI Model IBM is set to build custom AI foundation models in collaboration with L'Oreal to advance the creation of sustainable cosmetics. L’Oreal price target lowered to EUR 355 from EUR 365 at Jefferies Jefferies analyst Molly Wylenzek lowered the firm’s price target on L’Oreal (LRLCY) to EUR 355 from EUR 365 and keeps a Hold rating on the shares. Global beauty undershot the long-term trend in the second half of 2024 as China and the U.S. decelerated further, the firm notes. But sequential improvement Q4 on Q3 is providing some hope that market risk is no longer to the downside, Jefferies adds. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. IBM to buy Oracle consultancy, and partner with L’Oréal The acquisition aims to enhance IBM's Oracle solutions across North America, the UK, and Ireland, addressing complexities in public sector cloud transformations. L’Oréal, IBM collab on AI model development The beauty company wants to use the technology to help meet sustainability goals and improve efficiency. L'Oreal acquires South Korea's Dr.G in skincare deal with Migros French cosmetics giant L'Oreal said on Monday it had agreed to buy Gowoonsesang Cosmetics, which includes South Korean skincare brand Dr.G., from Swiss retailer Migros. The Korean beauty market is dominated by local brands known for being among the world's most innovative, and increasingly popular overseas as part of a trend for 'K-Beauty'. Dr.G will meet rising demand for K-Beauty and effective yet affordable skincare, L'Oreal said in a statement, adding that it has a growing pan-Asian presence and global growth potential. Performance Overview Trailing total returns as of 3/3/2025, which may include dividends or other distributions. Benchmark is CAC 40 Return LOR.HM CAC 40 YTD +2.41% +10.85% 1-Year -19.21% +3.11% 3-Year +7.45% +28.27%